EyePoint Pharmaceuticals Inc (EYPT)
11.66
-0.40
(-3.32%)
USD |
NASDAQ |
Nov 04, 13:03
EyePoint Pharmaceuticals Total Assets (Quarterly): 324.25M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 324.25M |
| March 31, 2024 | 329.25M |
| December 31, 2023 | 355.18M |
| September 30, 2023 | 160.04M |
| June 30, 2023 | 175.66M |
| March 31, 2023 | 154.59M |
| December 31, 2022 | 180.36M |
| September 30, 2022 | 220.49M |
| June 30, 2022 | 233.43M |
| March 31, 2022 | 244.56M |
| December 31, 2021 | 263.37M |
| September 30, 2021 | 168.25M |
| June 30, 2021 | 178.82M |
| March 31, 2021 | 187.14M |
| December 31, 2020 | 91.72M |
| September 30, 2020 | 76.79M |
| June 30, 2020 | 69.68M |
| March 31, 2020 | 80.29M |
| December 31, 2019 | 72.97M |
| September 30, 2019 | 79.07M |
| June 30, 2019 | 91.33M |
| March 31, 2019 | 81.85M |
| September 30, 2018 | 88.86M |
| June 30, 2018 | 71.67M |
| March 31, 2018 | 50.16M |
| Date | Value |
|---|---|
| December 31, 2017 | 14.20M |
| September 30, 2017 | 13.33M |
| June 30, 2017 | 18.68M |
| March 31, 2017 | 17.50M |
| December 31, 2016 | 19.75M |
| September 30, 2016 | 24.93M |
| June 30, 2016 | 31.62M |
| March 31, 2016 | 36.16M |
| December 31, 2015 | 23.95M |
| September 30, 2015 | 27.46M |
| June 30, 2015 | 32.37M |
| March 31, 2015 | 35.70M |
| December 31, 2014 | 40.18M |
| September 30, 2014 | 43.74M |
| June 30, 2014 | 22.67M |
| March 31, 2014 | 26.02M |
| December 31, 2013 | 20.82M |
| September 30, 2013 | 22.74M |
| June 30, 2013 | 16.25M |
| March 31, 2013 | 19.12M |
| December 31, 2012 | 21.04M |
| September 30, 2012 | 23.34M |
| June 30, 2012 | 20.60M |
| March 31, 2012 | 22.83M |
| December 31, 2011 | 24.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
69.68M
Minimum
Jun 2020
355.18M
Maximum
Dec 2023
187.73M
Average
178.82M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Cassava Sciences Inc | 243.57M |
| Adverum Biotechnologies Inc | 253.80M |
| Regenxbio Inc | 569.38M |
| Editas Medicine Inc | 384.80M |
| Apellis Pharmaceuticals Inc | 904.48M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 95.94M |
| Shareholders Equity (Quarterly) | 228.30M |
| Current Ratio | 4.749 |
| Net Debt Paydown Yield | 1.53% |